UFC heavyweight Marcos Rogerio de Lima suspended one year

Combat Sports Anti-Doping (CSAD) announced that Marcos Rogerio De Lima, of Sao Paulo, Brazil, has accepted a one-year period of ineligibility for a violation of the UFC Anti-Doping Policy (UFC ADP), according to Report.

UFC said in a statement that De Lima tested positive for the presence of Anastrozole, a prohibited at all times substance in the class of Hormone and Metabolic Modulators on the UFC Prohibited List from an out-of-competition sample collected from him on January 13, 2025.

"De Lima submitted extensive medical documentation confirming a medical condition which necessitated the prescribed treatment of anastrozole. Anastrozole was clearly listed on the label’s listed ingredient of the prescribed, compounded substance that he consumed. However, De Lima neither checked on the prohibited status himself of the prescription before using it, nor contacted anyone within the UFC Anti-Doping Compliance Team for help to check the status of the prescription," reads the statement.

Additionally, this is De Lima’s second violation under the UFC ADP, the first arising from a contaminated supplement he received and consumed from a compounding pharmacy in Brazil in 2017. His 2017 violation was also for the presence of Anastrozole in his system.